Soley Therapeutics uses proprietary imaging, AI, and automation to capture human cell responses to stress and drug exposure. This biology-first approach translates whole-cell information into first-in-class medicines with speed and scale. The company advances a pipeline of innovative therapeutics across oncology and complex non-oncology diseases.
Funding
$290M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional drug discovery methods are often inefficient and time-consuming, requiring extensive trial-and-error to identify promising drug candidates. Understanding the complex interplay of cellular responses to various stimuli remains a significant challenge, hindering the development of effective treatments for diseases with limited therapeutic options.
Solution
Soley Therapeutics offers a high-throughput platform that decodes cellular responses using AI and machine learning to accelerate drug discovery and development. The platform treats the cell as a natural sensor, interpreting its internal flow of information to identify potential drug candidates in a target-agnostic manner. By harnessing cells’ anticipatory biological capabilities and leveraging AI/ML, Soley's platform efficiently evaluates a wide range of compounds and their effects on cellular behavior. This approach enables the identification of novel drug candidates and facilitates the development of targeted therapies for various diseases. The platform's ability to interpret nuanced cellular responses allows for a more effective and streamlined drug discovery process.
Target Audience
The primary target audience includes pharmaceutical companies, biotechnology firms, and research institutions involved in drug discovery and development.
Features
- High-throughput screening platform for evaluating drug candidates
- AI/ML-driven analysis of cellular responses
- Target-agnostic approach to drug discovery
- Decodes cellular language to identify potential drug candidates
- Utilizes cells as natural sensors to assess drug efficacy